MOTORGRAFT

Pharmaceutical products for treatment of the nervous system of the human body; cells for medical or clinical use; gene therapy and prophylaxis products, namely, gene transfer, regulation, modulation and delivery products in the nature of pharmaceutical preparations for the treatment of motor neuron disease, blood disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, vascular disorders, disorders arising from improper vascularization and single gene disorders; pharmaceutical substances and preparations namely, vaccines, genetically engineered proteins, enzymes and enzyme preparations for medical diagnostic use; retroviral vector and retroviral vector manufacturing preparations for use in gene delivery; pharmaceutical and biochemical preparations for the treatment of single gene disorders; human motor neurons for medical use, namely, replacing endogenous motor neurons; instruments and apparatus for the administration of gene and antibody-based therapy and prophylaxis preparations and substances, namely, pre-filled vials, syringes and injectors for medical purposes, all for the treatment of motor neuron disease, single gene disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, blood disorders, vascular disorders and disorders arising from inappropriate vascularization